Genedata has Successfully Collaborated with Egis Pharmaceuticals PLC to Develop a Precision Medicine Tool for Rheumatoid Arthritis

/in , /by

A novel approach to guide infliximab therapy selection for rheumatoid arthritis patients Basel, Switzerland and Budapest, Hungary—Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, and Egis Pharmaceuticals PLC (Egis), one of the leading European pharmaceutical companies, announce their collaboration to develop a precision medicine tool for rheumatoid arthritis. Rheumatoid arthritis is a […]

Read more →

Fluidigm Announces New Co-Marketing Program under Collaboration Agreement with Visiopharm, Offering AI-Based Image Analysis Software

/in , /by

Native Reading of Hyperion Imaging System Data Files on the Visiopharm Platform to Streamline Data Analysis for ResearchersSOUTH SAN FRANCISCO, Calif. — Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced a new co-marketing program to offer Visiopharm® image analysis software for faster and […]

Read more →

Dotmatics partners with RockStep Solutions to provide an integrated solution for digitalized in vivo drug discovery

/in , /by

Integration of RockStep’s in vivo study management software with Dotmatics’ cloud-first R&D platform will streamline experiments and workflows RockStep’s Climb software will be available from Dotmatics Bishop’s Stortford, UK, and Portland, ME, USA: Dotmatics Ltd, an Insightful Science company that provides leading-edge scientific informatics software to drive the automation of lab data workflows and accelerate critical R&D discovery, […]

Read more →

Biognosys Supports Cancer Scout, a Large-Scale Multi-Omics Research Project to Accelerate Personalized Cancer Medicine

/in , /by

Cancer Scout combines Genomics, Proteomics, and Pathology data through Artificial Intelligence into a “digital biopsy” that supports early, accurate cancer diagnosis and treatment SCHLIEREN, (Zurich, Switzerland) – Biognosys, a leader in next-generation proteomics solutions for drug discovery and development, announces today that it is supporting Cancer Scout as Proteomics provider. Cancer Scout is a large-scale joint […]

Read more →

Teledyne CETAC Technology Partners with University of Az LaserChron Facility

/in , , , /by

Omaha, NE. Teledyne CETAC Technologies is pleased to announce their partnership with the LaserChron facility at the University of Arizona (ALC). The beautiful ALC facility in Tucson will act as Teledyne CETAC Technology’s North American Demo Lab, hosting visitors from across the globe as well as offering virtual support. The unparalleled experience of the ALC […]

Read more →

Navigo Proteins GmbH Announces Extension of Partnership with ITM for Targeted Radio Conjugates

/in , , , /by

HALLE/SAALE, Germany — Navigo Proteins, a premier protein engineering company developing optimized scaffold protein-based affinity ligands from its Precision Targeting toolbox today announces the extension of their ongoing partnership with ITM SE, a leading radiopharmaceutical biotech company. Under the terms of the collaboration agreement, the companies work together to develop targeted radiopharmaceutical candidates for the treatment of […]

Read more →

Malvern Panalytical Joins Wiley’s KnowItAll Raman Spectral Identification Partner Program

/in , /by

Malvern Panalytical, a leading analytical instrumentation supplier, has joined Wiley’s KnowItAll Raman Spectral Identification partner program.  As a KnowItAll Raman Spectral Identification Partner, Malvern Panalytical will bundle its Morphologi 4-ID instrument with a one-year subscription to Wiley’s KnowItAll Raman Identification Pro package. This package includes a complete solution for spectral analysis that combines a year subscription to […]

Read more →

Twist Bioscience and CENTOGENE to Develop Advanced Sequencing Tools to Make Genetic Testing Rapidly Accessible for More Patients With Rare Diseases

/in , , , /by

Combining Expertise to Advance Precision Medicine, While Enabling a More Efficient and Timely Diagnosis of Rare Diseases Around the World SOUTH SAN FRANCISCO, Calif. — Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Centogene N.V. (Nasdaq: CNTG), a commercial-stage company […]

Read more →

KNAUER NOW EXCLUSIVE DISTRIBUTOR FOR ELSD DETECTORS FROM SEDERE

/in , /by

Berlin: Evaporative light scattering detectors (ELSD) are needed in liquid chromatography whenever the target substances do not show UV absorption and are therefore undetectable with conventional UV and DAD detectors. KNAUER has had the LT-ELSD detectors from SEDERE in its sales portfolio for some time – and from now on became the exclusive distributor for […]

Read more →

Merck Licenses Foundational CRISPR Technology to Cellecta, Paving Path for Development of Next-Generation Treatments

/in , /by

Merck today announced that its Life Science business sector has signed an agreement licensing its patented CRISPR-Cas9 technology to Cellecta, Inc., a functional genomics products and services provider … Merck’s fundamental genome-editing tool helps identify innovative treatments in cellular and genetic diseases Company’s licensing enables researchers and scientists to advance treatments for inherited blood disorders, […]

Read more →